| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 10/21/2008 | US7439237 e.g. 1-(4-amino-3-chloro-5-trifluoromethyl-benzyl)-2-oxo-2-[4-(2-piperidin-1-yl-ethyl)-piperidin-1-yl]-ethyl 4-(2-oxo-1 ,2,4,5-tetrahydro-benzo[d][1,3]diazepin-3-yl)-piperidine-1-carboxylate; calcitonin gene related peptide antagonist; migraine or cluster headaches, non-insulin-dependent diabetes |
| 10/21/2008 | US7439207 2,6 substituted pyridine-3-carbonyl derivatives serving as plant protection agents having herbicidal action |
| 10/21/2008 | CA2372156C Solvates of pymetrozine |
| 10/21/2008 | CA2368823C Use of dopamine d3 receptor ligands for producing medicaments for treating kidney disorders |
| 10/21/2008 | CA2336624C Farnesyl protein transferase inhibitors with in vivo radiosensitizing properties |
| 10/21/2008 | CA2210913C Antipsychotic 4-(1h-indolyl-1-yl)-1-substituted piperidine derivatives |
| 10/21/2008 | CA2146707C Substituted n-heteroaroylguanidines as inhibitors of na+/h+ exchange |
| 10/16/2008 | WO2008124703A2 Development of molecular imaging probes for carbonic anhydrase-ix using click chemistry |
| 10/16/2008 | WO2008124614A1 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto |
| 10/16/2008 | WO2008124610A1 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto |
| 10/16/2008 | WO2008124524A2 Aryl sulfonamide compounds as modulators of the cck2 receptor |
| 10/16/2008 | WO2008124183A1 Methods of treating or preventing emesis using growth hormone secretagogues |
| 10/16/2008 | WO2008124083A2 Aurora kinase modulators and method of use |
| 10/16/2008 | WO2008124075A1 Novel 2,3-benzodiazepine derivatives and their use as antipsychotic agents |
| 10/16/2008 | WO2008123821A1 4, 5-dihydro-lh-imidazol-2-amine derivatives for use in the treatment of respiratory, cardiovascular, neurological or gastrointestinal disorders |
| 10/16/2008 | WO2008123701A1 Novel crystalline bepotastine metal salt hydrate, method for preparing same, and pharmaceutical composition comprising same |
| 10/16/2008 | WO2008123582A1 Tetrahydroisoquinoline compound |
| 10/16/2008 | WO2008123395A1 Ocular hypotensive agent comprising compound capable of inhibiting histone deacetylase as active ingredient |
| 10/16/2008 | WO2008123017A1 Novel diamide derivative |
| 10/16/2008 | WO2008122858A2 Crystalline forms of 6- [2- (methylcarbamoyl) phenylsulfanyl] -3-e- [2- (pyridin-2-yl) ethenyl] indazole suitable for the treatment of abnormal cell growth in mammals |
| 10/16/2008 | WO2008122784A1 Quinolines and their therapeutic use |
| 10/16/2008 | WO2008122765A1 New compounds and their uses 707 |
| 10/16/2008 | WO2008122561A1 Pyridinone derivative for the treatment of premature ejaculation |
| 10/16/2008 | WO2008122510A1 1-(1-benzylpiperidin-4-yl)benzimidaz0le -5-carboxylic acid derivatives for the treatment of diabetes mellitus |
| 10/16/2008 | WO2008122378A1 Novel pyridine derivatives, processes for preparing them, pharmaceutical compositions thereof |
| 10/16/2008 | WO2008103068A3 Method for producing 2-anilinopyrimidines or the salts thereof |
| 10/16/2008 | WO2008091752A3 Quinolone carboxylic acids, derivatives thereof, processes for their preparation and their use as antibacterial agents |
| 10/16/2008 | WO2008082502A3 Process for preparing 2-amino-5-cyanobenzoic acid derivatives |
| 10/16/2008 | WO2008079988A3 Quinazolines for pdk1 inhibition |
| 10/16/2008 | WO2008076883A3 Triazine derivatives and their therapeutical applications |
| 10/16/2008 | WO2008048503A3 Imidazole substitured pyrazole kinase inhibitors |
| 10/16/2008 | WO2008021725A3 Chemical compounds |
| 10/16/2008 | WO2007105058A8 Pyrazole compounds |
| 10/16/2008 | US20080255363 Novel Form of S-Omeprazole |
| 10/16/2008 | US20080255362 Cyclic amide derivative, and its production and use |
| 10/16/2008 | US20080255359 Novel Chemical Process For the Synthesis of Quinoline Compounds |
| 10/16/2008 | US20080255358 imidazopyridine compounds such as 8-{[(2,6-Dimethylphenyl)methyl]oxy}-2,3-dimethyl-6-phenylimidazo[1,2-a]pyridine, used as adenosine triphosphatase inhibitors, for therapy of gastrointestinal disorders |
| 10/16/2008 | US20080255352 Cyclic amide derivative, and its production and use |
| 10/16/2008 | US20080255350 Substituted aza-indoles as inhibitors of poly(adp-ribose) polymerase (parp) |
| 10/16/2008 | US20080255207 5-Thioxo-1,5-Dihydro-2H-Pyrrol-2-One Derivatives As Liver X Receptor Modulators |
| 10/16/2008 | US20080255205 protein kinase receptors (like Tie-2 and Aurora) modulators; to treat cancer, inflammation and related disorders; to regulate active angiogenesis, cell-signal transduction; 5-(3-(1H-tetrazol-5-yl)pyridin-2-yloxy)-N-(3-chlorobenzyl)-2-fluorobenzamide |
| 10/16/2008 | US20080255201 Ppar active compounds |
| 10/16/2008 | US20080255200 Benzimidazole enriched with deuterium; administering along with other active drugs |
| 10/16/2008 | US20080255199 Using 2-(((4-x-3,5-dimethyl(or1-oxo)pyridin-2-yl)methylthio)5-methoxy-1H-benzimidazole where x is a leaving group; oxidation; using titanium complex catalyst and a base |
| 10/16/2008 | US20080255197 Aminoalkylpyridines; treating HIV infections; antiinflammatory agents; rheumatic diseases; elevating progesator and stem cell count |
| 10/16/2008 | US20080255196 Pesticide Thiazolyloxy Substituted Phenylamidine Derivatives |
| 10/16/2008 | US20080255195 Psyvhological disorders; cognition activators |
| 10/16/2008 | US20080255191 Benzylimidazolyl substituted 2-quinoline and quinazoline derivatives for use as farnesyl transferase inhibitors |
| 10/16/2008 | US20080255176 1-methyl-3 beta -hydroxymethyl-6-methoxy-1,2,3,4,4a alpha ,5,10, 10a beta -octahydrobenzo[q]quinoline; decrease on the intraocular pressure; glaucoma and myopia; excellent tolerability, and a long duration of action |
| 10/16/2008 | US20080255172 Pyrimidine derivatives |
| 10/16/2008 | US20080255155 Inhibit protein tyrosine kinase; treating cell proliferative diseases and conditions; N-(6-(2-Fluoro-4-(4,4,4-trifluoro-3-(4-fluorophenylamino)butanamido)phenoxy)pyrimidin-4-yl)pyrrolidine-1-carboxamide |
| 10/16/2008 | US20080255154 Cycloalkylcarbonyl-3H-spiro[2-benzofuran-1,3'-pyrrolidin]-3-ones: N-methyl-5-[4-(1-{[3-oxo-1'H,3H-spiro[2-benzofuran-1,3'-pyrrolidin]-1'-yl]carbonyl}cyclopropyl)phenyl]pyridine-2-carboxamide; 11- beta hydroxyl steroid dehydrogenase type 1 inhibitors; mineralcorticoid receptor antagonists; diabetes |
| 10/16/2008 | US20080255152 Diaryl ethers as opioid receptor antagonists |
| 10/16/2008 | US20080255144 (3'-Chloro-4-methanesulfonyl-biphenyl-2-yl)-[4-(3,4-dichloro-phenyl)-piperazin-1-yl]-methanone; neurological and neuropsychiatric disorders including schizophrenia |
| 10/16/2008 | US20080255143 Inhibitors of Akt Activity |
| 10/16/2008 | US20080255142 Substituted Piperidine Derivatives as Somatostatin Sst1 Receptor Antagonists |
| 10/16/2008 | US20080255141 Modulators of signal transduction mediated by certain native and/or mutant tyrosine kinases; antiproliferative, anticarcinogenic, antiallergen, and antiinflammatory agents; metabolic and neurodegenerative disorders |
| 10/16/2008 | US20080255138 Novel Polymorphic Form Of Imatinib Mesylate And A Process For Its Preparation |
| 10/16/2008 | US20080255137 N-Biaryl and N-Arylheteroaryl 2-Substituted Piperazine Derivatives as Modulators of the 5ht2c Receptor Useful for the Treatment of Disorders Related Thereto |
| 10/16/2008 | US20080255136 Pyrrolidones with anti-hiv activity |
| 10/16/2008 | US20080255134 Cardiotonic Compounds With Inhibitory Activity Against Beta-Adrenergic Receptors And Phosphodiesterase |
| 10/16/2008 | US20080255133 N-(2-aylamino)aryl sulfonamides such as N-(7-(4-bromo-2-fluorophenylamino)imidazo[1,2-b]pyridazin-6-yl)-1-(2-hydroxyethyl)cyclopropane-1-sulfonamide; mitogen-activated ERK activating kinase (MEK) inhibitors; antiproliferative, anticarcinogenic, and antiinflammatory agents |
| 10/16/2008 | US20080255126 Inhibitors of post-proline cleaving proteases |
| 10/16/2008 | US20080255122 Derivatives of Isothiazol-3(2H)-One 1,1-Dioxides as Liver X Receptor Modulators |
| 10/16/2008 | US20080255118 Cyanopyrimidinones |
| 10/16/2008 | US20080255116 Therapy for bacteria infections other than Mycibacterium infections; antibiotic resistance |
| 10/16/2008 | US20080255115 (5Z)-5-{[4-(4-pyridinyl)-6-quinolinyl]methylidene}-1,3-thiazolidine-2,4-dione; autoimmune disorders, inflammatory, cardiovascular, neurodegenerative diseases, allergy, asthma, pancreatitis, multiorgan failure, kidney diseases, platelet aggregation, sperm motility, transplantation rejection |
| 10/16/2008 | US20080255113 N-({1-[(cis-1,4-dihydroxycyclohexyl)methyl]piperidin-4-yl}methyl)-1-isopropyl-5-methyl-2-oxo-1, 2-dihydroquinoline-3-carboxamide ethanedioate; gastroesophageal reflux disease, non-ulcer dyspepsia, functional dyspepsia, irritable bowel syndrome |
| 10/16/2008 | US20080255109 Antigonadotrophins; breast and prostate cancer, endometriosis, benign prostate hyperplasia; regulation of fertility; 4-(3-Chloro-4-{{(4-chloro-benzenesulfonyl)-methyl-amino]-methyl}-thiophene-2-carbonyl)-3,4-dihydro-2H-benzo[1,4]oxazine-2carboxylic acid (3-methyl-[1,2,4]oxadiazol-5-ylmethyl)-amide |
| 10/16/2008 | US20080255095 Benzylamine analogues |
| 10/16/2008 | US20080255083 New pyridone derivates with mch antagonistic activity and medicaments comprising these compounds |
| 10/16/2008 | US20080254116 Delta and Epsilon Crystal Forms of Imatinib Mesylate |
| 10/16/2008 | US20080251758 Triazine Compounds Comprising Substituents Containing Amino Groups and Carboxyl Groups |
| 10/16/2008 | DE102007017884A1 Neue Vanilloid-Rezeptor Liganden und ihre Verwendung zur Herstellung von Arzneimitteln New vanilloid receptor ligands and their use for the preparation of medicaments |
| 10/16/2008 | CA2683434A1 Development of molecular imaging probes for carbonic anhydrase-ix using click chemistry |
| 10/16/2008 | CA2683431A1 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto |
| 10/16/2008 | CA2682822A1 Novel crystalline bepotastine metal salt hydrate, method for preparing same, and pharmaceutical composition comprising same |
| 10/16/2008 | CA2682287A1 1-(1-benzylpiperidin-4-yl)benzimidaz0le -5-carboxylic acid derivatives for the treatment of diabetes mellitus |
| 10/16/2008 | CA2681221A1 Isoquinolinone derivatives and their uses |
| 10/16/2008 | CA2680948A1 Methods of treating or preventing emesis using growth hormone secretagogues |
| 10/16/2008 | CA2680838A1 Intraocular pressure-lowering agent comprising compound having histone deacetylase inhibitory effect as active ingredient |
| 10/16/2008 | CA2680682A1 Quinolines and their therapeutic use |
| 10/15/2008 | EP1980558A1 Polycationic monochromophoric compounds of hydrazone type, dyeing compositions comprising same and dyeing method |
| 10/15/2008 | EP1979343A2 Bicyclic heteroaryl compounds as pde10 inhibitors |
| 10/15/2008 | EP1979342A1 Compounds for the inhibition of integrins and use thereof |
| 10/15/2008 | EP1979341A1 Trisubstituted amine compound |
| 10/15/2008 | EP1979340A2 S-omeprazole magnesium |
| 10/15/2008 | EP1979339A2 Novel cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors |
| 10/15/2008 | EP1979338A1 Cis-4, 5-biaryl-2-heterocyclic-imidazolines as mdm2 inhibitors |
| 10/15/2008 | EP1979332A1 Chemical compounds |
| 10/15/2008 | EP1979331A1 Trisubstituted amine compounds as inhibitors of -cholesteryl ester transfer protein cetp |
| 10/15/2008 | EP1979329A2 4-aryl-2-amino-pyrimidines or 4-aryl-2-aminoalkyl-pyrimidines as jak-2 modulators and methods of use |
| 10/15/2008 | EP1979325A1 Morpholino pyrimidine derivatives and their use in therapy |
| 10/15/2008 | EP1979324A2 Novel 2-amino-imidazole-4-one compounds and their use in the manufacture of a medicament to be used in the treatment of cognitive impairment, alzheimer's disease, neurodegeneration and dementia |
| 10/15/2008 | EP1979321A1 Novel pyridinylaminoalkylene- and pyridinyloxyalkylene-cyclopropanamines, process for the preparation thereof and pharmaceutical compositions containing them |
| 10/15/2008 | EP1979320A2 PIPERAZINES AND PIPERIDINES AS mGluR5 POTENTIATORS |
| 10/15/2008 | EP1979319A1 Novel dual nk2/nk3-antagonists, pharmaceutical compositions comprising them and processes for their preparations |
| 10/15/2008 | EP1979315A2 Methods for treating hepatitis c |
| 10/15/2008 | EP1979314A2 Indole sulfonamide modulators of progesterone receptors |
| 10/15/2008 | EP1747201B1 2h or 3h-benzo[e]indazol-1-yle carbamate derivatives, the preparation and therapeutic use thereof |